Andarix Takes on Late-Stage Lung Cancer, Gets Personal
BioWorld Today Contributing Writer
More people die of lung cancer than any other cancer. In 2010, 162,460 deaths were attributed to non-small-cell lung cancer (NSCLC), and 174,470 new diagnoses were made. Surgery is the first line of defense against lung cancer, but late-stage cancer is not resectable, and chemotherapy only increases survival by four months to five months.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST